Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Airflow Obstruction, Chronic

pyrrolidine dithiocarbamate has been researched along with Airflow Obstruction, Chronic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, H; Li, Q; Sun, Y; Xu, H; Zhu, Y1
Jiang, M; Wang, CM; Wang, HJ1
Chen, SX; Li, YQ; Ma, D; Ni, W; Xu, YJ; Yang, Z; Zhang, ZX1

Other Studies

3 other study(ies) available for pyrrolidine dithiocarbamate and Airflow Obstruction, Chronic

ArticleYear
Activation of hypoxia-inducible factor-1alpha via nuclear factor-kappa B in rats with chronic obstructive pulmonary disease.
    Acta biochimica et biophysica Sinica, 2010, Volume: 42, Issue:7

    Topics: Administration, Oral; Animals; Antioxidants; Blood Gas Analysis; Bronchoalveolar Lavage Fluid; Cytokines; Heme Oxygenase-1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Lipopolysaccharides; Lung; Male; NF-kappa B; Nicotiana; Pulmonary Disease, Chronic Obstructive; Pyrrolidines; Rats; Rats, Sprague-Dawley; Respiratory Function Tests; Reverse Transcriptase Polymerase Chain Reaction; Smoke; Thiocarbamates; Vascular Endothelial Growth Factor A

2010
Effect of NF‑κB inhibitor on high‑mobility group protein B1 expression in a COPD rat model.
    Molecular medicine reports, 2013, Volume: 7, Issue:2

    Topics: Animals; Disease Models, Animal; Gene Expression; HMGB1 Protein; Lung; Male; NF-kappa B; Pulmonary Disease, Chronic Obstructive; Pyrrolidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Thiocarbamates

2013
N-Acetyl-L-cysteine and pyrrolidine dithiocarbamate inhibited nuclear factor-kappaB activation in alveolar macrophages by different mechanisms.
    Acta pharmacologica Sinica, 2006, Volume: 27, Issue:3

    Topics: Acetylcysteine; Antioxidants; Cells, Cultured; Humans; I-kappa B Kinase; I-kappa B Proteins; Interleukin-1; Macrophages, Alveolar; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Pulmonary Disease, Chronic Obstructive; Pyrrolidines; Thiocarbamates; Tumor Necrosis Factor-alpha

2006